The Facts

The Coalition for Safe & Innovative Medicine supports creating a responsible pathway for biosimilars that will ensure patient safety, preserve incentives for innovation scientific lab report introduction example and lower consumer costs. The Pathway for Biosimilars Act 2009, which was introduced by Rep. Anna Eshoo, Rep. Jay Inslee and Rep. Joe Barton,power and responsibility essay strikes this balance.

More Information

In the column on the right side of this page, you will find links to facts about the scientific differences between biologic drugs and traditional pharmaceutical drugs, analysis of the competing pieces of legislation, an explanation on the challenges of making biosimilars, and more.